Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Ironwood Pharmaceuticals missed estimated earnings by 16.0%, reporting an EPS of $0.21 versus an estimate of $0.25.
Revenue was up $8.68 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 1.04% increase in the share price the next day.
Here's a look at Ironwood Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.35 | 0.31 | 0.22 | 0.21 |
| EPS Actual | 0.27 | 0.33 | 0.34 | 0.24 |
| Revenue Estimate | 109.87M | 105.40M | 93.10M | 95.20M |
| Revenue Actual | 117.13M | 103.75M | 104.03M | 88.84M |
To track all earnings releases for Ironwood Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
